Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.
Patrizia ViciLaura PizzutiEriseld KrasniqiAndrea BotticelliGennaro CilibertoMaddalena BarbaPublished in: Immunotherapy (2020)